PYCARD and Alzheimer disease: This study demonstrates that the mRNAs of inflammasome components (NLRP1, NLRP3, PYCARD, caspase 1, 5, and 8) and downstream effectors (IL-1β, IL-18) are upregulated in both severe and mild AD.